用户48783635432019-04-09 14:29
【汇众医疗】Navidea宣布重启NAV3-31的2b期临床试验,此后股价上升13%
$Navidea生物制药(NAVB)$ Navidea根据FDA的反馈,宣布重启对NAV3-31的2b期临床试验计划,评估成像剂Tc99m tilmanocept在类风湿性关节炎患者中的应用。此举促进该公司股价上升了13%。 查看全文网页链接查看全文
艾萨克的猫2018-10-23 23:00
$Navidea Biopharmaceuticals, Inc. (NAVB)$ Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced today the company will pr...查看全文
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2015-07-06 AccNo: 0001144204-15-041146 Size: 32 KB 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ CT ORDER - Confidential treatment order Filed: 2015-07-07 AccNo: 9999999997-15-011584 Size: 10 KB 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ ARS [Paper] - Annual Report to Security Holders Film#: 15008085 Filed: 2015-07-20 AccNo: 9999999997-15-012663 Size: 1 KB 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K/A [Amend] - Current report Filed: 2015-10-09 AccNo: 0001144204-15-058915 Size: 698 KBItem 9.01: Financial Statements and Exhibits 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2015-08-26 AccNo: 0001144204-15-052079 Size: 239 KBItem 1.01: Entry into a Material Definitive AgreementItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2015-08-05 AccNo: 0001144204-15-046370 Size: 139 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2015-07-28 AccNo: 0001144204-15-044602 Size: 15 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2015-07-21 AccNo: 0001144204-15-043445 Size: 48 KBItem 5.07: Submission of Matters to a Vote of Security HoldersItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2015-07-08 AccNo: 0001144204-15-041632 Size: 38 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem ...
$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2015-08-10 AccNo: 0000810509-15-000008 Size: 4 MB 网页链接